News

Read the latest updates about BioMarin and learn more about our science, our people and the communities we support.

Marie Josee Toutounji

A Family Legacy: Marie-Josee Toutounji Following in Her Parents’ Footsteps

December 22, 2025

Joyanna Hansen

Joyanna Hansen: A Journey from the Clinic to BioMarin

December 2, 2025

Camp Ellellbee Activities Photo

Community

Camp Ellellbee Creates Space for Connection, Joy and Open Conversations About Skeletal Conditions

November 17, 2025

Stories

All Stories

Donnie Mackenzie

Donnie Mackenzie: Rising to the Challenge to Deliver Transformative Therapies

January 5, 2026

Marie Josee Toutounji

A Family Legacy: Marie-Josee Toutounji Following in Her Parents’ Footsteps

December 22, 2025

Joyanna Hansen

Joyanna Hansen: A Journey from the Clinic to BioMarin

December 2, 2025

Roberto McLean

Roberto McLean Turns Military Discipline into Impact for Patients

November 24, 2025

Camp Ellellbee Activities Photo

Community

Camp Ellellbee Creates Space for Connection, Joy and Open Conversations About Skeletal Conditions

November 17, 2025

Christina Pao Signature Science

Christina Pao on Charting a New Course for Children with Hypochondroplasia

October 30, 2025

Press Releases

All Press Releases

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

December 19, 2025

BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England

November 11, 2025

FDA Accepts BioMarin’s PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria

October 29, 2025

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

October 27, 2025

BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

October 22, 2025